Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:DBTX

Decibel Therapeutics (DBTX) Stock Price, News & Analysis

Decibel Therapeutics logo

About Decibel Therapeutics Stock (NASDAQ:DBTX)

Advanced Chart

Key Stats

Today's Range
$4.90
$5.11
50-Day Range
$4.91
$5.23
52-Week Range
$1.61
$5.40
Volume
1.26 million shs
Average Volume
122,002 shs
Market Capitalization
$123.39 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive DBTX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Decibel Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

DBTX Stock News Headlines

Your Bank Account Is No Longer Safe
What If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what the Department of Justice just admitted in court—claiming cash isn't legally your property. What does that mean? It means Washington thinks they can seize, freeze, or drain your accounts—whenever they want.
The Best Noise-Cancelling Headphones
Decibel Therapeutics' CVR Appears Around Fair Value
See More Headlines

DBTX Stock Analysis - Frequently Asked Questions

Decibel Therapeutics, Inc. (NASDAQ:DBTX) issued its quarterly earnings results on Wednesday, November, 10th. The company reported ($0.66) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.43) by $0.23.

Decibel Therapeutics (DBTX) raised $100 million in an initial public offering (IPO) on Friday, February 12th 2021. The company issued 5,900,000 shares at $16.00-$18.00 per share. Citigroup, BMO Capital Markets, SVB Leerink and Barclays acted as the underwriters for the IPO.

Based on aggregate information from My MarketBeat watchlists, some other companies that Decibel Therapeutics investors own include Predictive Oncology (POAI), Ford Motor (F), Zomedica (ZOM), Wells Fargo & Company (WFC), Bank of America (BAC), JPMorgan Chase & Co. (JPM) and Abbott Laboratories (ABT).

Company Calendar

Last Earnings
11/10/2021
Today
7/08/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
NASDAQ:DBTX
CIK
1656536
Fax
N/A
Employees
68
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$63.01 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Book Value
$3.28 per share
Price / Book
1.50

Miscellaneous

Free Float
16,182,000
Market Cap
$123.39 million
Optionable
Not Optionable
Beta
-0.43
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for July 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (NASDAQ:DBTX) was last updated on 7/9/2025 by MarketBeat.com Staff
From Our Partners